Patents Represented by Law Firm White & Case
  • Patent number: 6668980
    Abstract: The isolation system and method comprise suspending an elevator platform from an upper portion of an elevator sling with upper tension members. In addition to being suspended from the sling by upper tension members, the elevator car platform may be secured to a lower portion of the sling from with lower tension members. The tension members preferably have an in-use frequency of vibration below the frequencies of the elevator system vibrations. In an alternative embodiment, upper vibration attenuating tension members may be used to suspend the elevator car platform and the platform may be secured to the lower portion of the sling with standard isolation mounts instead of lower tension members. The tension members employed by the present invention may be manufactured from cables containing aramid fibers, such as Kevlar® rope.
    Type: Grant
    Filed: July 6, 2001
    Date of Patent: December 30, 2003
    Assignee: Thyssen Elevator Capital Corp.
    Inventor: Rory Smith
  • Patent number: 6664094
    Abstract: This invention relates to mutants of Neisseria useful for vaccine preparation. Specifically this invention relates to mutants of Neisseria containing mutations in a major outer membrane protein gene such that no immunologically functional polypeptides encoded by said gene are produced. More specifically, the invention relates to a mutant strain of Neisseria gonorrhoeae having a mutation of the PIII gene and to vaccines derived therefrom.
    Type: Grant
    Filed: September 21, 1994
    Date of Patent: December 16, 2003
    Assignee: The Rockefeller University
    Inventors: Emil Claus Gotschlich, Lee Mark Wetzler, Milan Scott Blake, John Michael Koomey
  • Patent number: 6664069
    Abstract: The present invention relates to the use of GABAB receptor agonists for the inhibition of transient lower esophageal sphincter relaxations, and for the treatment of gastro-esophageal reflux disease.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: December 16, 2003
    Assignee: AstraZeneca AB
    Inventors: Paul L. R. Andrews, Anders Lehmann
  • Patent number: 6662660
    Abstract: The invention concerns an apparatus for inspecting and calculating the residual strength of an aramid fiber cable driving an elevator to determine when such cable is in need of replacement. The apparatus includes a transmitter for introducing an acoustic wave that will travel along the aramid fiber cable and a receiver for receiving the acoustic wave after its has traversed a designated section of the cable. The transmitter and receiver provide signals indicating the times the wave was sent by the transmitter and thereafter received by the receiver. From these signals, a program in the system calculates the wave velocity and the modulus, and the residual strength of the aramid cable.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: December 16, 2003
    Assignee: Thyssen Elevator Capital Corp.
    Inventor: Rory Smith
  • Patent number: 6660279
    Abstract: A primary package containing a low molecular weight peptide-based thrombin inhibitors which package is sealed with a rubber stopper or plunger containing bromobutyl rubber.
    Type: Grant
    Filed: January 17, 2003
    Date of Patent: December 9, 2003
    Assignee: AstraZeneca AB
    Inventors: Anna Lundgren, Mats Sundgren
  • Patent number: 6660879
    Abstract: A novel 3-aryl-2-hydroxypropionic acid derivative, a process and intermediate for its manufacture, pharmaceutical preparations containing it and the use of the compound in clinical conditions associated with insulin resistance.
    Type: Grant
    Filed: January 4, 2002
    Date of Patent: December 9, 2003
    Assignee: AstraZeneca AB
    Inventor: Kjell Andersson
  • Patent number: 6659514
    Abstract: An electromechanical interlock for a swinging elevator door is disclosed. The interlock comprises a pivotal hook member that may be attached to a swinging elevator door. The hook has a beak end and may pivot between a locked and an unlocked position. Disposed on the beak end is an electrical conductor. When the interlock is in the locked position, the beak end engages a lug and the conductor contacts electrical contacts to complete an electrical circuit. A solenoid pivots the hook from a locked position to an unlocked position. The electromechanical interlock may be adapted for use with sliding elevator doors as well as swinging doors.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: December 9, 2003
    Assignee: Thyssen Elevator Capital Corp.
    Inventor: Patrick M. Bass
  • Patent number: 6645848
    Abstract: This invention relates to a method of improving the fabrication of etched semiconductor devices by using a patterned adhesion promoter layer over a hydrocarbon planarization material. More specifically, the present invention improves the bonding of a metal interconnect layer to a hydrocarbon planarization material, such as polyimide, by inserting an adhesion promotion layer, such as silicon nitride, between the hydrocarbon planarization material and the metal interconnect layer. A process for improving the fabrication of etched semiconductor devices, comprises the steps of: (1) depositing a hydrocarbon planarization material over a substrate; (2) depositing an adhesion promoter over the hydrocarbon planarization material; (3) defining a first mask and etching back the adhesion promoter so as to form an adhesion promoter pad over a portion of the hydrocarbon planarization material; and (4) depositing a first metal over the adhesion promoter pad.
    Type: Grant
    Filed: June 1, 2001
    Date of Patent: November 11, 2003
    Assignee: Emcore Corporation
    Inventors: John R. Joseph, Wenlin Luo, Kevin L. Lear, Robert P. Bryan
  • Patent number: 6636581
    Abstract: An inspection system utilized to inspect a structure for particularities, including defects, includes a first gantry with a detector inspection device that is placed in a known position on one side of the structure, and a second gantry with a source inspection device that is placed on the other side of the structure. In an embodiment, the detector inspection device is an x-ray detector inspection device and the source inspection device is an x-ray source inspection device. The movement of the first and second gantries is controlled by a gantry control system. A data acquisition system controls the data, e.g., image, collection process. During the data collection process, the relative positions of the source and detector inspection devices are initialized. The detector and source inspection devices are then moved in synchronized motion to each data collection position, such that the relative alignment of the inspection devices is maintained.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: October 21, 2003
    Inventor: Michael R. Sorenson
  • Patent number: 6633792
    Abstract: This invention relates to a method for controlling the process of manufacturing a coating of a pharmaceutical product, comprising the steps of: performing a spectroscopic measurement on the coating; generating a sample vector of measurement values from the spectrometric measurement; condensing the measurement values into at least one principal parameter; comparing the principal parameter to a predetermined corresponding model parameter; determining deviations of the principal parameter from the corresponding model parameter and extracting information directly related to the quality of the coating; and controlling the process on the basis, at least partly, of the extracted information.
    Type: Grant
    Filed: September 9, 1999
    Date of Patent: October 14, 2003
    Assignee: AstraZeneca AB
    Inventors: Staffan Folestad, Ingela Niklasson Björn
  • Patent number: 6631538
    Abstract: The present invention provides a Self-Closing Clasp Assembly designed to allow a loose object to be easily attached to an object that is already being conveniently handled or carried by a person. The Self-Closing Clasp Assembly is comprised of three elements: a Self-Closing Element linked by an Elongated Element to a Connecting Element. The Self-Closing Element is sized to grasp around an object that is relatively structural in nature, such as a shoulder-bag strap, belt or strap on a golfbag and is designed to be operated with one hand. The Self-Closing Element preferably comprises a self-closing clasp, or ring. The Elongated Element can be rigid or flexible and is preferably formed by items such as one or more chain links, an adjustable or fixed-length strap, or a bar, and is preferably used to link the Self-Closing Element to the Connecting Element. The Connecting Element preferably consists of a self-closing clasp, clip, clasp, bolt, finial, or ring and is designed to be affixed to the loose object.
    Type: Grant
    Filed: November 10, 1999
    Date of Patent: October 14, 2003
    Inventor: Kathleen Cosgriff Carr
  • Patent number: 6630509
    Abstract: The present invention relates to certain phenalkyloxy-phenyl derivatives of formula (I) and analogs, to a process for preparing such compounds, which compounds have utility in treating clinical conditions associated with insulin resistance, to methods for their therapeutic use and to pharmaceutical compositions containing them.
    Type: Grant
    Filed: June 3, 2002
    Date of Patent: October 7, 2003
    Assignee: AstraZeneca AB
    Inventors: Jonas Fägerhag, Lanna Li, Eva-Lotte Lindstedt Alstermark
  • Patent number: 6629961
    Abstract: Method for the manufacture of a medical device which presents a hydrophilic surface coated elongate shaft for insertion into a body passageway comprising the steps of having the elongate shaft formed from a thermoplastic elastomer material selected from the group consisting of a polyether block amide and a styrene block copolymer and forming the hydrophilic coating on the elongate shaft by applying sequentially to the surface of the elongate shaft a solution comprising between 0.05 to 40% (weight to volume) of an isocyanate compound and a solution containing between 0.5 and 50% (weight to volume) of polyvinylpyrrolidone and curing at an elevated temperature.
    Type: Grant
    Filed: July 31, 1997
    Date of Patent: October 7, 2003
    Assignee: Astra Aktiebolag
    Inventors: Anette Israelsson, Jan Utas
  • Patent number: 6630600
    Abstract: Novel 3-aryl propionic acid derivatives and analogs, process and intermediate for their manufacture, pharmaceutical preparations containing them and the use of the compounds in clinical conditions associated with insulin resistance.
    Type: Grant
    Filed: July 20, 1999
    Date of Patent: October 7, 2003
    Assignee: AstraZeneca AB
    Inventors: Kjell Andersson, Maria Boije, Johan Gottfries, Tord Inghardt, Lanna Li, Eva-Lotte Lindstedt Alstermark
  • Patent number: 6627760
    Abstract: The present invention relates to a novel form of (S)-1-[N2-(1-carboxy-3-phenylpropyl]-L-lysyl]-L-proline known under the generic name lisinopril. Further, the present invention also relates to the use of the novel amorphous form of lisinopril for the treatment of hypertension and other cardiovascular diseases, pharmaceutical compositions containing it as well as processes for the preparation of the novel amorphous form of lisinopril.
    Type: Grant
    Filed: June 25, 2001
    Date of Patent: September 30, 2003
    Assignee: AstraZeneca AB
    Inventor: Ronald John Roberts
  • Patent number: 6623759
    Abstract: The invention relates to a stable medicament for oral administration which comprises (a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole, together with customary pharmaceutical adjuvants, (b) an intermediate layer applied onto the core, and (c) a gastric juice-resistant outer layer. The intermediate layer in (b) is formed as a reactive layer in which a gastric juice-resistant polymer layer material partially neutralized with alkali with cation exchange capacity is present. Further, a method for the production of the stable medicament is disclosed.
    Type: Grant
    Filed: September 5, 2001
    Date of Patent: September 23, 2003
    Assignee: AstraZeneca AB
    Inventors: Gerd-Ulfert Heese, Herbert Jünger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss
  • Patent number: 6619484
    Abstract: The present invention relates to a filter device, especially for a fluidized bed system and particularly for use in the pharmaceutical industry, for separating particles larger than a separating grain from an amount of particles in a fluid flow. The filter device includes a housing and at least one filter portion. A part of the housing is mounted for rotational movement, and the filter portion is provided in the housing, whereby the filter portion is movable upon rotation of the housing. The present invention also relates to a method for separating particles using such a filter device.
    Type: Grant
    Filed: August 25, 2000
    Date of Patent: September 16, 2003
    Assignee: AstraZeneca AB
    Inventor: Håkan Glad
  • Patent number: 6619434
    Abstract: A method and apparatus for utilizing unused power available in an elevator that is not fully loaded to improve the traffic handling capacity of an elevator system. The present invention can be used to provide an optimized velocity profile for the elevator based on the pre-designed power of the drive motor and the actual load in the elevator. By using the surplus power available the method and apparatus of the invention can achieve velocities higher than the design velocity of the system. The method also utilizes surplus torque available to the motor during a trip to produce an optimized velocity profile that has a short trip time, yet does not exceed the torque deliverable by the motor and does not exceed acceptable discomfort levels to the passengers or mechanical limitations on the system.
    Type: Grant
    Filed: March 28, 2002
    Date of Patent: September 16, 2003
    Assignee: Thyssen Elevator Capital Corp.
    Inventors: Rory Stephen Smith, Richard D. Peters
  • Patent number: 6617508
    Abstract: An efficient method of interconnecting a solar cell having at least two front surface contacts with a diode mounted on a front surface of the solar cell includes the act of forming at least a first recess on a front surface of the solar cell. A first solar cell contact is formed on the front surface in the first recess. A second solar cell contact is formed on the front surface. At least a first bypass diode is positioned at least partly within the recess. The bypass diode has a first diode contact and a second diode contact. The first solar cell contact is interconnected with the first diode contact. The second solar cell contact is interconnected with the second diode contact.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: September 9, 2003
    Assignee: Emcore Corporation
    Inventors: Louis C. Kilmer, Mark DeWitt, James Patrick Hanley, Peng-Kuen Chiang
  • Patent number: D484142
    Type: Grant
    Filed: June 13, 2001
    Date of Patent: December 23, 2003
    Assignee: Siemens Aktiengesellschaft
    Inventor: Ulrich Bungert